Physician profile
Timothy Cawlfield
NPI 1992900781
$1,037.65
in general payments reported to CMS, 2019-2025
9 companies · $79.60 in 2025
The $79.60 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $94.81 · 2021: $287 · 2022: $114 · 2023: $112 · 2024: $231 · 2025: $79.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $387.49 | 2019-2024 | Eliquis |
| Boston Scientific Corporation | $308.10 | 2020-2025 | Varithena Administration Pack |
| Medtronic, INC. | $177.78 | 2021 | |
| Medtronic Vascular, INC. | $57.92 | 2019-2020 | |
| Tactile Systems Technology INC | $44.64 | 2019-2025 | Flexitouch Plus, Nimbl |
| Organogenesis INC. | $22.24 | 2023 | Puraply |
| Smith+Nephew, INC. | $14.97 | 2019 | |
| Pfizer INC. | $13.43 | 2023 | |
| Biocompatibles, INC. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Cawlfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.